Leveraging AI to Streamline Spravato Prior Authorization for Clinicians
Leveraging AI to Streamline Spravato Prior Authorization for Clinicians The introduction of Spravato (esketamine) as a groundbreaking treatment for treatment-resistant depression has provided new hope for patients who have not responded to conventional therapies. However, obtaining prior authorization (PA) for Spravato can be a time-intensive process for clinicians, often requiring extensive documentation and coordination with […]
Leveraging AI to Streamline Spravato Prior Authorization for Clinicians Read More »